AU2003285281A8 - Topical application of curcumin for the treatment of peripheral neuropathy - Google Patents

Topical application of curcumin for the treatment of peripheral neuropathy

Info

Publication number
AU2003285281A8
AU2003285281A8 AU2003285281A AU2003285281A AU2003285281A8 AU 2003285281 A8 AU2003285281 A8 AU 2003285281A8 AU 2003285281 A AU2003285281 A AU 2003285281A AU 2003285281 A AU2003285281 A AU 2003285281A AU 2003285281 A8 AU2003285281 A8 AU 2003285281A8
Authority
AU
Australia
Prior art keywords
curcumin
treatment
topical application
peripheral neuropathy
neuropathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003285281A
Other versions
AU2003285281A1 (en
Inventor
Abdellatif Mahmoud Selim Hanaa
I Ahmed Elmallah
A I Mohamed Ibrahim
Saied Hafiz Gazareen Sanaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003285281A8 publication Critical patent/AU2003285281A8/en
Publication of AU2003285281A1 publication Critical patent/AU2003285281A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU2003285281A 2002-11-25 2003-11-23 Topical application of curcumin for the treatment of peripheral neuropathy Abandoned AU2003285281A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EG2002111270A EG23547A (en) 2002-11-25 2002-11-25 Preparation of a topical pharmaceutical preparation of curcumin alone or a combination of circumin plus capsaicin as an effective remedy for treatmentof peripheral neuropathies
EG2002111270 2002-11-25
PCT/EG2003/000011 WO2004047717A2 (en) 2002-11-25 2003-11-23 Topical application of curcumin for the treatment of peripheral neuropathy

Publications (2)

Publication Number Publication Date
AU2003285281A8 true AU2003285281A8 (en) 2004-06-18
AU2003285281A1 AU2003285281A1 (en) 2004-06-18

Family

ID=32946815

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003285281A Abandoned AU2003285281A1 (en) 2002-11-25 2003-11-23 Topical application of curcumin for the treatment of peripheral neuropathy

Country Status (3)

Country Link
AU (1) AU2003285281A1 (en)
EG (1) EG23547A (en)
WO (1) WO2004047717A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9393198B2 (en) 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
EP2685963A4 (en) * 2011-03-16 2014-11-19 Signpath Pharma Inc Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
US12004868B2 (en) 2011-06-03 2024-06-11 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
US10449193B2 (en) 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
WO2012167212A2 (en) 2011-06-03 2012-12-06 Signpath Pharma Inc. Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
DE112013004278T5 (en) 2012-08-31 2015-05-21 Signpath Pharma Inc. Curcumin-Er, a prolonged or sustained-release liposomal PLNA nanocurcum to minimize QT prolongation for cancer therapy
EP3082768B1 (en) 2013-12-18 2023-02-22 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
PT3277273T (en) 2015-03-31 2020-04-29 Kolinpharma S P A A composition for the treatment of neuropathies and/or neuropathic pain
US10668123B2 (en) 2015-04-27 2020-06-02 Omniactive Health Technologies Limited Capsicum compositions and uses thereof
CA3038813C (en) 2016-04-27 2021-08-24 Signpath Pharma, Inc. Prevention of drug-induced atrio-ventricular block
IT201700088621A1 (en) * 2017-08-01 2019-02-01 Inpha Duemila Srl Food supplements for use in the treatment of diseases associated with alterations of peripheral nerve trophism.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11246398A (en) * 1998-03-02 1999-09-14 Kyowa Hakko Kogyo Co Ltd Prophylactic or therapeutic agent for disorder caused by increment of lipoperoxide in vivo
JPH11246399A (en) * 1998-03-03 1999-09-14 Lion Corp Lipid metabolism improving composition

Also Published As

Publication number Publication date
WO2004047717A2 (en) 2004-06-10
WO2004047717A3 (en) 2004-09-23
EG23547A (en) 2006-05-10
AU2003285281A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
TWI345979B (en) Topical pharmaceutical compositions for the treatment of dermatitis
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
HUS1500048I1 (en) Topical formulation of ivermectin for the treatment of dermatological conditions
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
ZA200507346B (en) Topical formulation of ivermectin for the treatment of dermatological conditions
HUS2200036I1 (en) Use of dihydroimidazolones for the treatment of dogs
EP1682136A4 (en) Therapeutic compounds and uses thereof
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003285281A8 (en) Topical application of curcumin for the treatment of peripheral neuropathy
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
EP1551388A4 (en) Compounds useful for the treatment of cancer, compositions thereof and methods therewith
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
HUP0500199A3 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
AU2003258983A8 (en) Combinations for the treatment of fungal infections
GB0223650D0 (en) Psoriasis treatment
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2003252187A8 (en) Topical composition for the treatment of inflammatory conditions of the skin
AU2003227519A1 (en) The use of milnacipran for the treatment of tension-type headache
AU2003274067A1 (en) Compounds for the treatment of cough
GB0229986D0 (en) Treatment of materials
AU2002950148A0 (en) Pharmaceutical composition for the treatment of skin conditions
ZA200410074B (en) Topical composition for the treatment of inflammatory conditions of the skin
HU0303659D0 (en) Preventive composition decreasing the possible development of tumorous deseases
AU2002100471A4 (en) Timber treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase